Resident Seminar Webinar Series- Direct Oral Anticoagulants in Pediatric Patients

ALSHP 2025 Resident Seminar Webinar Series

Thursday February 13, 2025, 12 Noon CST

Intended Audience: Pharmacists

 PGY1 Pharmacy Resident, Children’s of Alabama

Program Director:   Deidra Schmidt, PharmD, AAHIVP

Pharmacist Learning Objectives

At the completion of this activity, the participant will be able to:

• Define FDA approved indications and dosing for direct oral anticoagulants (DOACs) in pediatrics

• Discuss how DOACs are currently being used outside of the scope of FDA approval
• Explain DOAC uses and efficacy in specific populations

• Recognize DOAC reversal agents and their indications

Alabama Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.  Each program is approved for 1 hr (0.1 ceu) CPE credit.  Participants must pre-register, participate in the entire presentation, and complete the online course evaluation to receive continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 60 days for participants who have successfully completed all requirements.  There is no fee for ALSHP member pharmacists. Non-member pharmacist fee: $25 which is refundable when joining ALSHP within 30 days of the program date. Participants in this activity are subject to the Terms and Conditions for ALSHP meetings and events. Contact mail@alshp.org for questions about this CPE activity. 

UAN:0172-0000-25-004-L01-P   Release Date 2/13/2025

See system requirements HERE

Webinar link and password will be sent with your registration confirmation. Please read it carefully.